The worldwide market for mucus clearance systems is
anticipated to grow from 2019 to 2027 at a CAGR of 7.3 percent.
Market Insights
According to the study quote presented at the
International Respiratory Societies Forum, around 65 million individuals around
the globe experience COPD with 3 million fatalities happening each year.
Constant exposure to lung irritants and concurrent respiratory infections is
accountable for chronic respiratory disease occurring around the world.
Browse
the full report at https://www.credenceresearch.com/report/mucus-clearance-devices-market
The biggest indication segment on the market for
mucus clearance systems is chronic obstructive pulmonary disease. Prolonged
exposure to pulmonary irritants is the main causative agent responsible for the
development of its illness etiology, causing serious harm to the reduced
reparatory tracts and pulmonary alveoli. Constant increase in global tobacco
consumption and rising alarming air pollution will further accentuate the rate
of COPD incidence globally. Because of the steady increase in the amount of
antibiotic-resistant patients suffering from acute lung infection,
bronchiectasis has received tremendous attention in the last century.
For the section of mucus clearance machines, the
high frequency chest wall oscillation system reigns in the product section.
Adding the recent value to the current device such as vibration at variable
intensities and frequency guarantees patient convenience and concordance.
Increasing demand from home care environments and rehabilitation centers further
enhance market growth for HFCWO devices. Due to its double advantage in
patients with cystic fibrosis such as clearance of excess fluids from the lungs
and significant reduction in gas trapping and enhancement in lung ventilation,
oscillating positive expiratory pressure will highlight outstanding development
during the forecast period.
North America accounts for a market share of 35.1%
and is the dominating regional segment for mucus clearance devices market.
Growing incidence of chronic pulmonary disease and subsequent growth in the
smoking population together drive the market growth in North America region.
According to the research findings of Center for Disease Control and Prevention
(CDC), 2017 report the number of deaths in the U.S. due to chronic lower
respiratory tract disease is 160,201, hence making it the 4th largest causes of
death in the region. Europe holds a market share of 29.5% primarily due to high
prevalence rate of cystic fibrosis in the European Union which is 0.79 per
10,000 people as quoted by European Respiratory Society (ERS). Asia Pacific
represents 16.8% market share owing to the significant rise in tobacco
consumption and developing healthcare infrastructure.
Medical device companies manufacturing mucus
clearance devices are Allergan, Plc., Electromed, Inc., Hill-Rom, Inc., Koninklijke
Philips N.V., Monaghan Medical Corporation, Respiratory Technologies, Inc.,
Smiths Medical, Thayer Medical Corporation and Vortran Medical Technology 1,
Inc.
Key Market Movements:
- Rising
prevalence of respiratory disease throughout the globe
- Supportive
regulatory environment for the development and sale of mucus clearance
devices
- Addition
of latest ergonomic features to the existing mucus clearance devices which
increases patient compliance and associated concordance
Download
Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59854
By Indication (2017–2027; US$ Mn)
- Bronchiectasis
- Cystic
Fibrosis
- Chronic
Obstructive Pulmonary Disease
- Others
By Product (2017–2027; US$ Mn)
- High
Frequency Chest Wall Oscillation Device
- Intrapulmonary
Percussive Ventilation Flutter Device
- Oscillating
Positive Expiratory Pressure Device
By Geography Segment (2017-2027; US$ Bn)
- North
America
- Europe
- Asia
Pacific (APAC)
- Middle
East & Africa (MEA)
- Latin
America
About Us
Credence Research is a worldwide market research and
counseling firm that serves driving organizations, governments, non-legislative
associations, and not-for-benefits. We offer our customers some assistance with
making enduring enhancements to their execution and understand their most
imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily
prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
Toll-Free (US/CANADA) Ph.:
+1-800-361-8290
No comments:
Post a Comment